Institutional investors have a lot riding on Relmada Therapeutics, Inc. (NASDAQ:RLMD) with 48% ownership

By Yahoo! Finance | Jul 11, 2024 at 04:31 PM EST

Research on ownership and analyst forecasts data are crucial in understanding stock opportunities. Institutions hold a significant stake in Relmada Therapeutics, influencing its performance. Analysts and ownership data help predict a stock's future growth potential.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.